By Drug Class / Mechanism

Surgical Implants & Biomaterials (Porous PE, Alloplastic, Bioresorbable) Market Analysis

Cross-industry research covering Surgical Implants & Biomaterials (Porous PE, Alloplastic, Bioresorbable) across 1 market reportspanning Pharmaceuticals & Medical Devices — Ophthalmic Surgery.

1 Reports

1 Industries

Reports Covering Surgical Implants & Biomaterials (Porous PE, Alloplastic, Bioresorbable)

Oculoplastic Surgery Market to Reach USD 8.4 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Medical Devices — Ophthalmic Surgery·Market: USD 4.8 Billion (2025)·CAGR: 7.2%

The largest single drug/device class by revenue, encompassing porous polyethylene orbital implants, hydroxyapatite enucleation implants, alloplastic orbital floor plates, and bioresorbable mesh; Stryker and Synthes dominate alongside Integra LifeSciences. Regulatory pathway is predominantly 510(k) for non-novel designs, with PMA required for Class III indication expansions.

31%

Market Share

5.4%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments